{"api":"v1","generated_at":"2026-10-02T16:17:46.681Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-imwg-myeloma-5ab0d6","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-imwg-myeloma-5ab0d6/at/2026-10-02T12-31Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-02T12:31:46.748Z","snapshot_stamp":"2026-10-02T12-31Z","endpoint":{"slug":"api-magentlab-com-api-calc-imwg-myeloma-5ab0d6","canonical_url":"https://api.magentlab.com/api/calc/imwg_myeloma","resource":"https://api.magentlab.com/api/calc/imwg_myeloma","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"IMWG 2014 myeloma requiring therapy (Rajkumar 2014). Met when clonal BMPC ≥10% or biopsy-proven plasmacytoma plus ≥1 MDE: hypercalcemia, renal insufficiency, anemia, osteolytic lesion (CRAB), or BMPC ≥60%, involved:uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L, or >1 focal MRI lesion ≥5 mm (SLiM). Not a diagnosis. Not smouldering MM, MGUS, POEMS, or amyloid. Not Greipp ISS or R-ISS. magent does not assay calcium, creatinine, hemoglobin, or FLC, and does not read MRI.","service_name":"magent","declared_category":null,"declared_tags":["imwg-2014","myeloma","hematology","crab","calculator"],"route_template":null,"registry_updated":"2026-09-28T15:12:54.131Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc imwg myeloma","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-02T12:31:46.748Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-02T12:31:46.748Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:12:54.002Z"},"validation":{"latest":{"observed_at":"2026-10-02T14:44:02.298Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-02"},"uptime":[{"days":7,"observed":6,"passed":6,"ratio":1},{"days":30,"observed":6,"passed":6,"ratio":1},{"days":90,"observed":6,"passed":6,"ratio":1}],"history_90d":[{"observed_at":"2026-10-02T14:44:02.298Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-02","state_changed":false},{"observed_at":"2026-10-01T07:39:38.736Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T06:57:50.667Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T19:16:04.731Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:56:42.270Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:42:39.685Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["imwg-2014","myeloma","hematology","crab","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/imwg_myeloma","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:12:54.002Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/imwg_myeloma","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"anemia":false,"bmpc_ge_60":false,"hypercalcemia":true,"mri_gt_1_focal":false,"flc_ratio_ge_100":false,"osteolytic_lesion":false,"renal_insufficiency":false,"clonal_bmpc_ge_10_or_plasmacytoma":true},{"anemia":false,"bmpc_ge_60":false,"hypercalcemia":true,"mri_gt_1_focal":false,"flc_ratio_ge_100":false,"osteolytic_lesion":false,"renal_insufficiency":false,"clonal_bmpc_ge_10_or_plasmacytoma":true}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/imwg_myeloma","count":2,"items":[{"anemia":false,"any_mde":true,"formula":"imwg_myeloma","myeloma":true,"citation":{"id":"rajkumar-2014","doi":"10.1016/S1470-2045(14)70442-5","pmid":"25439696","title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","source":"Lancet Oncol. 2014;15(12):e538-e548","authors":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BGM, San Miguel JF"},"criteria":[{"met":true,"factor":"clonal_bmpc_ge_10_or_plasmacytoma"},{"met":true,"factor":"hypercalcemia"},{"met":false,"factor":"renal_insufficiency"},{"met":false,"factor":"anemia"},{"met":false,"factor":"osteolytic_lesion"},{"met":false,"factor":"bmpc_ge_60"},{"met":false,"factor":"flc_ratio_ge_100"},{"met":false,"factor":"mri_gt_1_focal"},{"met":true,"factor":"any_mde"}],"bmpc_ge_60":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","hypercalcemia":true,"mri_gt_1_focal":false,"flc_ratio_ge_100":false,"osteolytic_lesion":false,"formula_expression":"myeloma iff clonal_bmpc_ge_10_or_plasmacytoma and ≥1 myeloma-defining event (hypercalcemia, renal_insufficiency, anemia, osteolytic_lesion, bmpc_ge_60, flc_ratio_ge_100, or mri_gt_1_focal) (Rajkumar 2014 IMWG definition of multiple myeloma requiring therapy). Not a diagnosis. Not smouldering MM, MGUS, POEMS, or amyloid. Not Greipp ISS. Not R-ISS","renal_insufficiency":false,"clonal_bmpc_ge_10_or_plasmacytoma":true},{"anemia":false,"any_mde":true,"formula":"imwg_myeloma","myeloma":true,"citation":{"id":"rajkumar-2014","doi":"10.1016/S1470-2045(14)70442-5","pmid":"25439696","title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","source":"Lancet Oncol. 2014;15(12):e538-e548","authors":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BGM, San Miguel JF"},"criteria":[{"met":true,"factor":"clonal_bmpc_ge_10_or_plasmacytoma"},{"met":true,"factor":"hypercalcemia"},{"met":false,"factor":"renal_insufficiency"},{"met":false,"factor":"anemia"},{"met":false,"factor":"osteolytic_lesion"},{"met":false,"factor":"bmpc_ge_60"},{"met":false,"factor":"flc_ratio_ge_100"},{"met":false,"factor":"mri_gt_1_focal"},{"met":true,"factor":"any_mde"}],"bmpc_ge_60":false,"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","hypercalcemia":true,"mri_gt_1_focal":false,"flc_ratio_ge_100":false,"osteolytic_lesion":false,"formula_expression":"myeloma iff clonal_bmpc_ge_10_or_plasmacytoma and ≥1 myeloma-defining event (hypercalcemia, renal_insufficiency, anemia, osteolytic_lesion, bmpc_ge_60, flc_ratio_ge_100, or mri_gt_1_focal) (Rajkumar 2014 IMWG definition of multiple myeloma requiring therapy). Not a diagnosis. Not smouldering MM, MGUS, POEMS, or amyloid. Not Greipp ISS. Not R-ISS","renal_insufficiency":false,"clonal_bmpc_ge_10_or_plasmacytoma":true}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["clonal_bmpc_ge_10_or_plasmacytoma","hypercalcemia","renal_insufficiency","anemia","osteolytic_lesion","bmpc_ge_60","flc_ratio_ge_100","mri_gt_1_focal"],"properties":{"anemia":{"type":"boolean","description":"Anemia as assigned by the caller (Rajkumar 2014 CRAB): hemoglobin value >20 g/L below the lower limit of normal or hemoglobin <100 g/L. true or false. magent does not assay hemoglobin."},"bmpc_ge_60":{"type":"boolean","description":"Clonal bone marrow plasma cells ≥60%, as assigned by the caller (Rajkumar 2014 SLiM). true or false. magent does not read a marrow."},"hypercalcemia":{"type":"boolean","description":"Hypercalcemia as assigned by the caller (Rajkumar 2014 CRAB): serum calcium >0.25 mmol/L (>1 mg/dL) above the upper limit of normal or >2.75 mmol/L (>11 mg/dL). true or false. magent does not assay calcium."},"mri_gt_1_focal":{"type":"boolean","description":">1 focal lesion on MRI, each ≥5 mm, as assigned by the caller (Rajkumar 2014 SLiM). true or false. magent does not read MRI."},"flc_ratio_ge_100":{"type":"boolean","description":"Involved:uninvolved serum free light-chain ratio ≥100 and involved free light chain ≥100 mg/L, as assigned by the caller as this one flag (Rajkumar 2014 SLiM). true or false. magent does not assay free light chains."},"osteolytic_lesion":{"type":"boolean","description":"One or more osteolytic lesions on skeletal radiography, CT, or PET-CT, as assigned by the caller (Rajkumar 2014 CRAB). If marrow clonal plasma cells are <10%, more than one bone lesion is required to distinguish solitary plasmacytoma; that is the caller’s assignment of this flag. true or false. magent does not read imaging."},"renal_insufficiency":{"type":"boolean","description":"Renal insufficiency as assigned by the caller (Rajkumar 2014 CRAB): creatinine clearance <40 mL/min or serum creatinine >177 µmol/L (>2 mg/dL). true or false. magent does not assay creatinine."},"clonal_bmpc_ge_10_or_plasmacytoma":{"type":"boolean","description":"Clonal bone marrow plasma cells ≥10% or biopsy-proven bony or extramedullary plasmacytoma, as assigned by the caller (Rajkumar 2014 IMWG entry for myeloma requiring therapy). true or false. When false, myeloma is false even if a myeloma-defining event is true. magent does not read a marrow or biopsy."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"IMWG 2014 myeloma requiring therapy (Rajkumar 2014). Met when clonal BMPC ≥10% or biopsy-proven plasmacytoma plus ≥1 MDE: hypercalcemia, renal insufficiency, anemia, osteolytic lesion (CRAB), or BMPC ≥60%, involved:uninvolved FLC ratio ≥100 with involved FLC ≥100 mg/L, or >1 focal MRI lesion ≥5 mm (SLiM). Not a diagnosis. Not smouldering MM, MGUS, POEMS, or amyloid. Not Greipp ISS or R-ISS. magent does not assay calcium, creatinine, hemoglobin, or FLC, and does not read MRI.","lastUpdated":"2026-09-28T15:12:54.131Z","serviceName":"magent","x402Version":2}]}}